| Recruiting | Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugat Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis, Haemophilus Influenzae Type B Infection | Phase 1 | 2025-12-19 |
| Recruiting | A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Heal Pneumococcal Infections, Streptococcal Infections, Bacterial Infections | Phase 3 | 2025-11-14 |
| Recruiting | A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years Tuberculosis | Phase 1 | 2025-11-13 |
| Active Not Recruiting | Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | 2025-03-23 |
| Active Not Recruiting | A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Diphtheria, Tetanus, Pertussis | Phase 2 / Phase 3 | 2024-12-20 |
| Recruiting | A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers Poliomyelitis | Phase 1 / Phase 2 | 2024-12-19 |
| Active Not Recruiting | A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Ye Meningococcal Meningitis | Phase 3 | 2024-12-14 |
| Active Not Recruiting | Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine Haemophilus Influenzae Type B Infection | Phase 1 | 2024-11-15 |
| Active Not Recruiting | Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants Epidemic Meningitis | Phase 4 | 2024-06-12 |
| Completed | A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a P Tetanus | Phase 3 | 2024-03-20 |
| Active Not Recruiting | A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (C Meningococcal Meningitis | Phase 3 | 2024-03-20 |
| Active Not Recruiting | A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Meningococcal Meningitis | Phase 3 | 2024-03-01 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) Poliomyelitis | Phase 1 | 2024-01-15 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Tetanus | Phase 1 | 2023-12-20 |
| Active Not Recruiting | A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) Diphtheria, Tetanus, Pertussis | Phase 1 | 2023-12-06 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years Herpes Zoster | Phase 1 | 2023-11-07 |
| Active Not Recruiting | Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM Epidemic Meningitis | Phase 4 | 2023-09-20 |
| Completed | A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Y Epidemic Meningitis | Phase 3 | 2023-09-16 |
| Active Not Recruiting | A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed( Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | 2023-08-11 |
| Completed | Clinical Trial of Recombinant Pneumococcal Protein Vaccine Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections | Phase 1 | 2023-03-11 |
| Withdrawn | A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in COVID-19 | Phase 3 | 2022-11-30 |
| Completed | IH Convidecia as Second Booster Dose Against Breakthrough Infections COVID-19 | Phase 3 | 2022-09-20 |
| Completed | Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older COVID-19 | Phase 2 | 2022-07-06 |
| Completed | Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older COVID-19 | Phase 1 | 2022-05-17 |
| Terminated | A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children COVID-19 | Phase 3 | 2022-02-25 |
| Withdrawn | Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Effica COVID-19 | Phase 3 | 2021-12-15 |
| Completed | A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age COVID-19 | N/A | 2021-06-03 |
| Completed | Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for I COVID-19 | Phase 1 / Phase 2 | 2021-04-21 |
| Completed | Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) Pneumococcal Infections, Streptococcal Infections, Bacterial Infections | Phase 3 | 2021-04-13 |
| Completed | A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) COVID-19 | Phase 2 | 2020-09-24 |
| Completed | Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above COVID-19 | Phase 3 | 2020-09-15 |
| Unknown | Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada COVID-19 | Phase 1 / Phase 2 | 2020-08-01 |
| Completed | Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above Pneumococcal Infections, Streptococcal Infections, Bacterial Infections | Phase 1 | 2020-05-18 |
| Completed | Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Ads Diphtheria, Tetanus, Pertussis | Phase 1 | 2020-04-28 |
| Completed | Phase Ⅰa Clinical Trial of a Pneumococcal Vaccine Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections | EARLY_Phase 1 | 2020-04-10 |
| Completed | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults COVID-19 | Phase 1 | 2020-03-16 |